Literature DB >> 11822821

Testosterone stimulates growth of tibial epiphyseal growth plate and insulin-like growth factor-1 receptor abundance in hypophysectomized and castrated rats.

M Phillip1, G Maor, S Assa, A Silbergeld, Y Segev.   

Abstract

Puberty is associated with an increase in the plasma concentration of sex steroids, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Gonadal steroid hormones are important for the normal pubertal growth spurt and skeletal growth. The mechanism by which gonadal steroids induces skeletal growth is still not fully understood. To study the GH-independent effect of testosterone on growth, we investigated the effect of testosterone injections on the tibial epiphyseal growth plate (EGP) in an in vivo model of hypophysectomized and castrated male rats. Four groups (six animals each) of 28-d-old male rats were studied. Groups A, B, and C were hypophysectomized and castrated and received 500 microg/(kg x d) of hydrocortisone and 15 microg/(kg x d) of levothyroxine sodium. Groups A and B were also treated with daily sc injections of 10 microg of testosterone/100 g of body wt and 100 microg of testosterone/100 g of body wt, respectively, for 7 d. Group C was injected with vehicle alone. Group D were intact animals injected with saline (controls). Animals were sacrificed on 8 d. As expected, serum GH levels were found to be very low (1.13+/-0.1 ng/mL) in the hypophysectomized animals (group C, hypopit), and testosterone treatment did not change them significantly. Serum IGF-1 decreased from 502.9+/-13 ng/mL in group D to 167+/-41.4 ng/mL in group C (p < 0.001). Testosterone therapy had no stimulatory effect on serum IGF-1 levels in the hypopit + low-dose group (A) (220+/-94.8 ng/mL) and had an inhibitory effect in the hypopit + high-dose group (B) (39.3+/-17.5). Histomorphometric determinations demonstrated an EGP width of 472.3+/-39 microm in the intact animals but only 336.9+/-1.6 microm in the hypopit group (C) (p < 0.01). High-dose testosterone treatment (group B) significantly increased the EGP width (to 438.8+/-27.8), (p < 0.001), whereas low-dose testosterone (group A) did not. Immunohistochemistry studies revealed that the levels of IGF-1 in the EGP of the control animals were almost negligible and that testosterone did not change them. However, testosterone increased in a dose-dependent manner the abundance of IGF-1 receptor EGP. We conclude that testosterone has a direct, local, GH-independent effect on the EGP growth and IGF-1 receptor abundance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11822821     DOI: 10.1385/ENDO:16:1:01

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

Review 1.  Radioimmunoassays for IGFs and IGFBPs.

Authors:  W F Blum; B H Breier
Journal:  Growth Regul       Date:  1994-02

Review 2.  Structure and function of the insulin-like growth factor I receptor.

Authors:  L Sepp-Lorenzino
Journal:  Breast Cancer Res Treat       Date:  1998-02       Impact factor: 4.872

3.  Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males.

Authors:  R G Thompsom; A Rodriguez; A Kowarski; C J Migeon; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

4.  Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels.

Authors:  A M Luna; D M Wilson; C J Wibbelsman; R C Brown; R J Nagashima; R L Hintz; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

5.  Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A.

Authors:  M A Rivarola; J A Phillips; C J Migeon; J J Heinrich; B J Hjelle
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

6.  Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.

Authors:  B S Keenan; G E Richards; S W Ponder; J S Dallas; M Nagamani; E R Smith
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

7.  Growth hormone and testosterone can independently stimulate the growth of hypophysectomized prepubertal lambs without any alteration in circulating concentrations of insulin-like growth factors.

Authors:  I R Young; S Mesiano; R Hintz; D J Caddy; M M Ralph; C A Browne; G D Thorburn
Journal:  J Endocrinol       Date:  1989-06       Impact factor: 4.286

8.  Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus.

Authors:  F Nieves-Rivera; A D Rogol; J D Veldhuis; D K Branscom; P M Martha; W L Clarke
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

9.  Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat.

Authors:  M Phillip; T Palese; E R Hernandez; C T Roberts; D LeRoith; A A Kowarski
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

10.  Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth.

Authors:  R M Bala; J Lopatka; A Leung; E McCoy; R G McArthur
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

View more
  5 in total

1.  Longitudinal relationship between insulin-like growth factor-1 levels and vertical facial growth.

Authors:  Mohamed I Masoud; Hussain Y A Marghalani; Najlaa M Alamoudi; Douaa El Derw; Ibrahim M Masoud; Nour F Gowharji
Journal:  J Orofac Orthop       Date:  2015-09       Impact factor: 1.938

2.  Transdermal delivery of human growth hormone through RF-microchannels.

Authors:  Galit Levin; Amikam Gershonowitz; Hagit Sacks; Meir Stern; Amir Sherman; Sergey Rudaev; Inna Zivin; Moshe Phillip
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

3.  Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor.

Authors:  Barbara Schreier; Sindy Rabe; Sabrina Winter; Stefanie Ruhs; Sigrid Mildenberger; Bettina Schneider; Maria Sibilia; Michael Gotthardt; Sabine Kempe; Karsten Mäder; Claudia Grossmann; Michael Gekle
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

Review 4.  A concise review of testosterone and bone health.

Authors:  Nur-Vaizura Mohamad; Ima-Nirwana Soelaiman; Kok-Yong Chin
Journal:  Clin Interv Aging       Date:  2016-09-22       Impact factor: 4.458

5.  Role of Expression of Inflammatory Mediators in Primary and Recurrent Lumbar Disc Herniation.

Authors:  Yasar Dagistan; Selma Cukur; Emine Dagistan; Ali Riza Gezici
Journal:  J Korean Neurosurg Soc       Date:  2016-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.